Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma
P Arumugam, R George, VP Jayaseelan - Archives of oral biology, 2021 - Elsevier
Abstract Objective N6-Methyladenosine (m6A) is the most common RNA modification in
eukaryotic mRNAs and growing evidence suggests that m6A modification and its regulators …
eukaryotic mRNAs and growing evidence suggests that m6A modification and its regulators …
[HTML][HTML] Shooting at moving and hidden targets—tumour cell plasticity and the notch signalling pathway in head and neck squamous cell carcinomas
J Kałafut, A Czerwonka, A Anameriç… - Cancers, 2021 - mdpi.com
Simple Summary Cancers in the head and neck region are often aggressive and poorly
respond to both irradiation or chemotherapy. Chemotherapy is currently limited by a small …
respond to both irradiation or chemotherapy. Chemotherapy is currently limited by a small …
[HTML][HTML] Beyond keratinocyte differentiation: emerging new biology of small proline-rich proteins
A Zabini, Y Zimmer, M Medová - Trends in cell biology, 2023 - cell.com
Small proline-rich proteins (SPRRPs) are traditionally known for their function in keratinocyte
homeostasis. Recent evidence demonstrates their involvement in additional diverse …
homeostasis. Recent evidence demonstrates their involvement in additional diverse …
[HTML][HTML] Single-cell transcriptomic analysis reveals the critical molecular pattern of UV-induced cutaneous squamous cell carcinoma
G Yan, L Li, S Zhu, Y Wu, Y Liu, L Zhu, Z Zhao… - Cell Death & …, 2021 - nature.com
Cutaneous squamous cell carcinoma (cSCC) is the second most common nonmelanoma
skin cancer characterized by high invasiveness, heterogeneity, and mainly occurs in the …
skin cancer characterized by high invasiveness, heterogeneity, and mainly occurs in the …
[HTML][HTML] High risk-human papillomavirus in HNSCC: Present and future challenges for epigenetic therapies
L Ghiani, S Chiocca - International Journal of Molecular Sciences, 2022 - mdpi.com
Head and Neck Squamous Cell Carcinoma (HNSCC) is a highly heterogeneous group of
tumors characterized by an incidence of 650,000 new cases and 350,000 deaths per year …
tumors characterized by an incidence of 650,000 new cases and 350,000 deaths per year …
[HTML][HTML] TEAD4 as an Oncogene and a Mitochondrial Modulator
SC Hsu, CY Lin, YY Lin, CC Collins… - Frontiers in Cell and …, 2022 - frontiersin.org
TEAD4 (TEA Domain Transcription Factor 4) is well recognized as the DNA-anchor protein
of YAP transcription complex, which is modulated by Hippo, a highly conserved pathway in …
of YAP transcription complex, which is modulated by Hippo, a highly conserved pathway in …
The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma
P Muthumanickam… - Journal of Oral …, 2024 - Wiley Online Library
Background Emerging research has identified the N6‐methyladenosine (m6A) modification
and its regulatory enzymes, including methyltransferase 5 (METTL5), as critical players in …
and its regulatory enzymes, including methyltransferase 5 (METTL5), as critical players in …
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel
JE Mann, A Kulkarni, AC Birkeland, J Kafelghazal… - Head & …, 2019 - Wiley Online Library
Background Laryngeal squamous cell carcinomas (LSCCs) have a high risk of recurrence
and poor prognosis. Patient‐derived cancer cell lines remain important preclinical models …
and poor prognosis. Patient‐derived cancer cell lines remain important preclinical models …
[HTML][HTML] Precise identification of recurrent somatic mutations in oral cancer through whole-exome sequencing using multiple mutation calling pipelines
Understanding the genomic alterations in oral carcinogenesis remains crucial for the
appropriate diagnosis and treatment of oral squamous cell carcinoma (OSCC). To unveil the …
appropriate diagnosis and treatment of oral squamous cell carcinoma (OSCC). To unveil the …
[HTML][HTML] Dual inhibition of autophagy and PI3K/AKT/MTOR pathway as a therapeutic strategy in head and neck squamous cell carcinoma
Genomic analyses of head and neck squamous cell carcinoma (HNSCC) have highlighted
alterations in the phosphatidylinositol 3-kinase (PI3K) signaling pathway, presenting a …
alterations in the phosphatidylinositol 3-kinase (PI3K) signaling pathway, presenting a …